Saskia de Groot

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Health Information

Systematic Review

Cross Sectional

Top Venues

Health economics

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Valérie J van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Isaac Corro Ramos, Saskia le Cessie, Matthijs M Versteegh, Job van Exel, null null
Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study. Neurology 102 (6) (2024)
Valérie J van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Isaac Corro Ramos, Saskia le Cessie, Matthijs M Versteegh, Job van Exel, null null
Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study. Neurology 102 (6) (2024)
Valérie J van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Isaac Corro Ramos, Saskia le Cessie, Matthijs M Versteegh, Job van Exel, null null
Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study. Neurology 102 (6) (2024)
Valérie J van Hezik-Wester, Saskia de Groot, Tim Kanters, Louis Wagner, Jacqueline Ardesch, Werner Brouwer, Isaac Corro Ramos, Saskia le Cessie, Matthijs M Versteegh, Job van Exel, null null
Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study. Neurology 102 (6) (2024)
Philip Klein, Hedwig Blommestein, Maiwenn Al, Benedetta Pongiglione, Aleksandra Torbica, Saskia de Groot
Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose? Health economics (2022)
Bogdan Grigore, Oriana Ciani, Florian Dams, Carlo Federici, Saskia de Groot, Meilin Möllenkamp, Stefan Rabbe, Kosta Shatrov, Antal Tamás Zemplényi, Rodney S Taylor
Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. PharmacoEconomics 38 (10) (2021)